In addition, there was a statistically significant increase in serum tumor markers levels CEA, CA19-9 and CA72-4 among symptomatic patients in comparison to non-symptomatic ones, at (P < 0.05) as shown in Table 5. The gene discussed is CEACAM5; the disease is neoplasm.